The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Opioid-Induced Tolerance and Hyperalgesia
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Opioid Abuse in Chronic Pain — Misconceptions and Mitigation Strategies
Volkow, N. D., & McLellan, A. T. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1507771 · Cited by 1,305
The prevalence of chronic pain in United States adults: Results of an Internet-based survey
Johannes, C. B., Le, T. K., Zhou, X., Johnston, J. A., & Dworkin, R. H. (2010) · The Journal of Pain · doi:10.1016/j.jpain.2010.07.002 · Cited by 1,252
Pathological pain and the neuroimmune interface
Grace, P. M., Hutchinson, M. R., Maier, S. F., & Watkins, L. R. (2014) · Nature Reviews Immunology · doi:10.1038/nri3621 · Cited by 932
Breivik, H., Eisenberg, E., & O’Brien, T. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-1229 · Cited by 643
The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy
Tanga, F. Y., Nutile-McMenemy, N., & DeLeo, J. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501634102 · Cited by 634
Raghavendra, V., Tanga, F. Y., & DeLeo, J. A. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03514.x · Cited by 580
Evidence for the Neuropeptide Cholecystokinin as an Antagonist of Opiate Analgesia
Faris, P. L., Komisaruk, B. R., Watkins, L. R., & Mayer, D. J. (1983) · Science · doi:10.1126/science.6294831 · Cited by 578
Evidence that opioids may have toll-like receptor 4 and MD-2 effects
Hutchinson, M. R., Zhang, Y., Shridhar, M., Evans, J. H., Buchanan, M. M., Zhao, T. X., Slivka, P. F., Coats, B. D., Rezvani, N., Wieseler, J., et al. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.08.004 · Cited by 573
Morphine activates neuroinflammation in a manner parallel to endotoxin
Wang, X., Loram, L. C., Ramos, K., de Jesus, A. J., Thomas, J., Cheng, K., Reddy, A., Somogyi, A. A., Hutchinson, M. R., Watkins, L. R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200130109 · Cited by 517
Watkins, L. R., Hutchinson, M. R., Rice, K. C., & Maier, S. F. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.08.002 · Cited by 438
Morphine hyperalgesia gated through microglia-mediated disruption of neuronal Cl− homeostasis
Ferrini, F., Trang, T., Mattioli, T.-A. M., Laffray, S., Del'Guidice, T., Lorenzo, L.-E., Castonguay, A., Doyon, N., Zhang, W., Godin, A. G., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3295 · Cited by 437
Johnston, I. N., Milligan, E. D., Wieseler-Frank, J., Frank, M. G., Zapata, V., Campisi, J., Langer, S., Martin, D., Green, P., Fleshner, M., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1850-04.2004 · Cited by 433
Tanga, F. Y., Raghavendra, V, & DeLeo, J. A. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2003.06.002 · Cited by 375
Vanderah, T. W., Suenaga, N. M. H., Ossipov, M. H., Malan, T. P., Lai, J., & Porreca, F. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-01-00279.2001 · Cited by 335
Glia: novel counter-regulators of opioid analgesia
Watkins, L. R., Hutchinson, M. R., Johnston, I. N., & Maier, S. F. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.10.001 · Cited by 328
Bruera, E., Pereira, J., Watanabe, S., Belzile, M., Kuehn, N., & Hanson, J. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960815)78:4<852::aid-cncr23>3.0.co;2-t · Cited by 313
Hutchinson, M. R., Lewis, S. S., Coats, B. D., Skyba, D. A., Crysdale, N. Y., Berkelhammer, D. L., Brzeski, A., Northcutt, A., Vietz, C. M., Judd, C. M., et al. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.09.012 · Cited by 303
Heroin "Overdose" Death: Contribution of Drug-Associated Environmental Cues
Siegel, S., Hinson, R. E., Krank, M. D., & McCully, J. (1982) · Science · doi:10.1126/science.7200260 · Cited by 301
Descending modulation of pain: the GABA disinhibition hypothesis of analgesia
Lau, B. K., & Vaughan, C. W. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.07.010 · Cited by 297
Toll, L., Bruchas, M. R., Calo', G., Cox, B. M., & Zaveri, N. T. (2016) · Pharmacological Reviews · doi:10.1124/pr.114.009209 · Cited by 297
Opioid Induced Hyperalgesia: Clinical Implications for the Pain Practitioner
Silverman, S. M. (2009) · Pain Physician · doi:10.36076/ppj.2009/12/679 · Cited by 238
Simonin, F., Schmitt, M., Laulin, J.-P., Laboureyras, E., Jhamandas, J. H., MacTavish, D., Matifas, A., Mollereau, C., Laurent, P., Parmentier, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502090103 · Cited by 230
Biological and Pharmacological Aspects of the NK1-Receptor
Garcia-Recio, S., & Gascón, P. (2015) · BioMed Research International · doi:10.1155/2015/495704 · Cited by 226
Vaughan, C. W., & Christie, M. J. (1997) · The Journal of Physiology · doi:10.1113/jphysiol.1997.sp021872 · Cited by 223
Eidson, L. N., & Murphy, A. Z. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1609-13.2013 · Cited by 222
Xie, J. Y., Herman, D. S., Stiller, C.-O., Gardell, L. R., Ossipov, M. H., Lai, J., Porreca, F., & Vanderah, T. W. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4054-04.2005 · Cited by 208
Gruber-Schoffnegger, D., Drdla-Schutting, R., Hönigsperger, C., Wunderbaldinger, G., Gassner, M., & Sandkühler, J. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.5087-12.2013 · Cited by 207
Torrecilla, M., Marker, C. L., Cintora, S. C., Stoffel, M., Williams, J. T., & Wickman, K. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-11-04328.2002 · Cited by 206
Conversion ratios for opioid switching in the treatment of cancer pain: a systematic review
Mercadante, S., & Caraceni, A. (2011) · Palliative Medicine · doi:10.1177/0269216311406577 · Cited by 191
Self-citationOpioid Tolerance–In Search of the Holy Grail
Kieffer, B. L., & Evans, C. J. (2002) · Cell · doi:10.1016/s0092-8674(02)00666-9 · Cited by 191
Regulation of Opioid Tolerance by let-7 Family MicroRNA Targeting the μ Opioid Receptor
He, Y., Yang, C., Kirkmire, C. M., & Wang, Z. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2419-10.2010 · Cited by 186
Lewis, S. S., Hutchinson, M. R., Rezvani, N., Loram, L. C., Zhang, Y., Maier, S. F., Rice, K. C., & Watkins, L. R. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2009.10.011 · Cited by 184
Xu, J.-T., Zhao, J.-Y., Zhao, X., Ligons, D., Tiwari, V., Atianjoh, F. E., Lee, C.-Y., Liang, L., Zang, W., Njoku, D., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci70236 · Cited by 169
A review of the role of anti‐opioid peptides in morphine tolerance and dependence
Rothman, R. B. (1992) · Synapse · doi:10.1002/syn.890120206 · Cited by 168
Beutler, B., Du, X., & Poltorak, A. (2001) · Journal of Endotoxin Research · doi:10.1177/09680519010070040901 · Cited by 167
NMDA-Receptor Antagonists and Opioid Receptor Interactions as Related to Analgesia and Tolerance
Price, D. D., Mayer, D. J., Mao, J., & Caruso, F. S. (2000) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(99)00121-9 · Cited by 161
Doehring, A., Oertel, B. G., Sittl, R., & Lötsch, J. (2013) · Pain · doi:10.1016/j.pain.2012.06.011 · Cited by 160
Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling
Melief, E. J., Miyatake, M., Bruchas, M. R., & Chavkin, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000751107 · Cited by 154
Ossipov, M. H., Lai, J. Y., Vanderah, T. W., & Porreca, F. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00410-7 · Cited by 149
Horvath, R. J., Romero-Sandoval, A. E., & Leo, J. A. D. (2010) · Pain · doi:10.1016/j.pain.2010.02.042 · Cited by 142
μ‐Opioid receptor desensitization: Is morphine different?
Connor, M. A., Osborne, P. B., & Christie, M. J. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705938 · Cited by 141
Molecular Biology of Opioid Analgesia
Pasternak, G. W. (2005) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2005.01.011 · Cited by 140
Eidson, L. N., Inoue, K., Young, L. J., Tansey, M. G., & Murphy, A. Z. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.131 · Cited by 140
Rapid Switching From Morphine to Methadone in Cancer Patients With Poor Response to Morphine
Mercadante, S., Casuccio, A., & Calderone, L. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3307 · Cited by 139
Self-citationOpioid and chemokine receptor crosstalk: a promising target for pain therapy?
Parsadaniantz, S. M., Rivat, C., Rostène, W. H., & Goazigo, A. R.-L. (2015) · Nature reviews. Neuroscience · doi:10.1038/nrn3858 · Cited by 138
Nitroxidative signaling mechanisms in pathological pain
Grace, P. M., Gaudet, A. D., Staikopoulos, V., Maier, S. F., Hutchinson, M. R., Salvemini, D., & Watkins, L. R. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.10.003 · Cited by 128
Epigenetics in pain and analgesia: An imminent research field
Doehring, A., Geißlinger, G., & Lötsch, J. (2010) · European Journal of Pain · doi:10.1016/j.ejpain.2010.06.004 · Cited by 126
Zhang, N., Rogers, T. J., Caterina, M. J., & Oppenheim, J. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.594 · Cited by 123
Allostatic mechanisms of opioid tolerance beyond desensitization and downregulation
Cahill, C. M., Walwyn, W., Taylor, A. M. W., Pradhan, A. A. A., & Evans, C. J. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.08.002 · Cited by 122
Zhao, Y.-L., Chen, S.-R., Chen, H., & Pan, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.378737 · Cited by 121
Chieng, B. C. H., & Christie, M. J. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb16209.x · Cited by 116
Zhou, D., Chen, M.-L., Zhang, Y.-Q., & Zhao, Z.-Q. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5377-09.2010 · Cited by 114
Cancer-Related Neuropathic Pain
Edwards, H. L., Mulvey, M. R., & Bennett, M. (2019) · Cancers · doi:10.3390/cancers11030373 · Cited by 113
Hyperalgesia in Heroin Dependent Patients and the Effects of Opioid Substitution Therapy
Compton, P. A., Canamar, C. P., Hillhouse, M. P., & Ling, W. W. (2012) · Journal of Pain · doi:10.1016/j.jpain.2012.01.001 · Cited by 110
Epigenetic Regulation of Opioid-Induced Hyperalgesia, Dependence, and Tolerance in Mice
Liang, D., Li, X., & Clark, J. D. (2012) · Journal of Pain · doi:10.1016/j.jpain.2012.10.005 · Cited by 103
Morphine-Induced Chemotaxis and Brain-Derived Neurotrophic Factor Expression in Microglia
Takayama, N., & Ueda, H. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3170-04.2005 · Cited by 98
Opioid Poorly-Responsive Cancer Pain. Part 3. Clinical Strategies to Improve Opioid Responsiveness
Mercadante, S., & Portenoy, R. K. (2001) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(01)00250-0 · Cited by 97
Self-citationMcNally, G. P. (1999) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(99)00040-8 · Cited by 95
Opioid switching in cancer pain: From the beginning to nowadays
Mercadante, S., & Bruera, E. D. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.12.011 · Cited by 95
Self-citationMercadante, S., Fulfaro, F., & Casuccio, A. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00102-8 · Cited by 92
Self-citationCodeine-induced hyperalgesia and allodynia: investigating the role of glial activation
Johnson, J. L., Rolan, P. E., Johnson, M., Bobrovskaya, L., Williams, D. B., Johnson, K., Tuke, J., & Hutchinson, M. R. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.121 · Cited by 92
Counter-Regulation of Opioid Analgesia by Glial-Derived Bioactive Sphingolipids
Muscoli, C., Doyle, T. M., Dagostino, C., Bryant, L., Chen, Z., Watkins, L. R., Ryerse, J. S., Bieberich, E., Neumman, W., & Salvemini, D. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2391-10.2010 · Cited by 92
Chen, M., Cao, H., Chu, Y., Cheng, L., Liang, L., Zhang, Y., & Zhao, Z.-Q. (2012) · Journal of Pain · doi:10.1016/j.jpain.2012.06.007 · Cited by 89
Analgesic synergy between opioid and α 2 ‐adrenoceptors
Chabot‐Doré, A., Schuster, D. J., Stone, L. S., & Wilcox, G. L. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12695 · Cited by 89
Mattioli, T.-A. M., Leduc‐Pessah, H., Skelhorne‐Gross, G., Nicol, C. J. B., Milne, B., Trang, T., & Cahill, C. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097361 · Cited by 89
Hyperalgesia and opioid switching
Mercadante, S., & Arcuri, E. (2005) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/104990910502200411 · Cited by 88
Self-citationElhabazi, K., Trigo, J., Mollereau, C., Moulédous, L., Zajac, J., Bihel, F. J. ‐., Schmitt, M., Bourguignon, J., Méziane, H., Petit‐Demoulière, B., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01563.x · Cited by 87
Opioid Tolerance – A Predictor of Increased Length of Stay and Higher Readmission Rates
Gulur, P. (2014) · Pain Physician · doi:10.36076/ppj.2014/17/e503 · Cited by 85
Wu, Q., Zhang, L., Law, P., Wei, L., & Loh, H. H. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.053462 · Cited by 81
Targeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations
Arout, C. A., Edens, E., Petrakis, I. L., & Sofuoglu, M. (2015) · CNS Drugs · doi:10.1007/s40263-015-0255-x · Cited by 80
Hull, L. C., Llorente, J., Gabra, B. H., Smith, F. L., Kelly, E., Bailey, C. P., Henderson, G., & Dewey, W. L. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.161455 · Cited by 73
CXCL12/CXCR4 axis: an emerging neuromodulator in pathological pain
Luo, X., Wang, X., Xia, Z., Chung, S. K., & Cheung, C. W. (2015) · Reviews in the Neurosciences · doi:10.1515/revneuro-2015-0016 · Cited by 72
Therapeutic targeting of the ceramide-to-sphingosine 1-phosphate pathway in pain
Salvemini, D., Doyle, T. M., Kress, M., & Nicol, G. D. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.12.001 · Cited by 71
Opioid Poorly-Responsive Cancer Pain. Part 2
Mercadante, S., & Portenoy, R. K. (2001) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(00)00236-0 · Cited by 70
Self-citationLidocaine for Cancer Pain in Adults: A Systematic Review and Meta-Analysis
Lee, J. T., Sanderson, C. R., Xuan, W., & Agar, M. R. (2019) · Journal of Palliative Medicine · doi:10.1089/jpm.2018.0257 · Cited by 67
Depner, U. B., Reinscheid, R. K., Takeshima, H., Brune, K., & Zeilhofer, H. U. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02676.x · Cited by 64
Death-associated protein kinase 1 phosphorylates NDRG2 and induces neuronal cell death
You, M., Kim, B. M., Chen, C.-H., Begley, M. J., Cantley, L. C., & Lee, T. H. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.114 · Cited by 63
The CCK-B receptor antagonist Cl 988 reverses tolerance to morphine in rats
Hoffmann, O. I., & Wiesenfeld‐Hallin, Z. (1994) · Neuroreport · doi:10.1097/00001756-199412000-00040 · Cited by 60
Dexmedetomidine Infusion for the Management of Opioid-Induced Hyperalgesia
Belgrade, M. J., & Hall, S. (2010) · Pain Medicine · doi:10.1111/j.1526-4637.2010.00973.x · Cited by 60
Pain Among High-Risk Patients on Methadone Maintenance Treatment
Voon, P., Hayashi, K., Milloy, M., Nguyen, P., Wood, E., Montaner, J., & Kerr, T. H. (2015) · Journal of Pain · doi:10.1016/j.jpain.2015.06.003 · Cited by 59
Reddy, A. S., Yennurajalingam, S., Pulivarthi, K., Palla, S. L., Wang, X., Kwon, J. H., Frisbee‐Hume, S. E., & Bruera, E. D. (2012) · The Oncologist · doi:10.1634/theoncologist.2012-0269 · Cited by 58
Src family kinases involved in CXCL12-induced loss of acute morphine analgesia
Rivat, C., Sebaihi, S., Steenwinckel, J. V., Fouquet, S., Kitabgi, P., Pohl, M., Parsadaniantz, S. M., & Goazigo, A. R.-L. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.11.010 · Cited by 49
Let-7 microRNAs and Opioid Tolerance
Hé, Y., & Wang, Z. J. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00110 · Cited by 49
Little, J. W., Cuzzocrea, S., Bryant, L., Esposito, E., Doyle, T. M., Rausaria, S., Neumann, W. L., & Salvemini, D. (2013) · Pain · doi:10.1016/j.pain.2013.02.018 · Cited by 45
OPRM1 Methylation Contributes to Opioid Tolerance in Cancer Patients
Viet, C. T., Dang, D., Aouizerat, B. E., Miaskowski, C. A., Ye, Y., Viet, D. T., Ono, K., & Schmidt, B. L. (2017) · Journal of Pain · doi:10.1016/j.jpain.2017.04.001 · Cited by 44
N-terminal Tyrosine Residues within the Potassium Channel Kir3 Modulate GTPase Activity of Gαi
Ippolito, D. L., Temkin, P. A., Rogalski, S. L., & Chavkin, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204407200 · Cited by 40
Involvement of matrix metalloproteinase-9 in the development of morphine tolerance.
Nakamoto, K., Kawasaki, S., Kobori, T., Fujita-Hamabe, W., Mizoguchi, H., Yamada, K., Nabeshima, T., & Tokuyama, S. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.03.006 · Cited by 40
Connor, M. A., Bagley, E. E., Chieng, B. C. H., & Christie, M. J. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12673 · Cited by 39
Opioid plasma concentration during switching from morphine to methadone: preliminary data
Mercadante, S., Bianchi, M., Villari, P., Ferrera, P., Casuccio, A., Fulfaro, F., & Gebbia, V. (2003) · Supportive Care in Cancer · doi:10.1007/s00520-003-0440-1 · Cited by 37
Self-citationWilson‐Poe, A. R., Jeong, H., & Vaughan, C. W. (2017) · The Journal of Physiology · doi:10.1113/jp274157 · Cited by 37
Tumati, S., Largent‐Milnes, T. M., Keresztes, A. I., Yamamoto, T., Vanderah, T. W., Roeske, W. R., Hruby, V. J., & Varga, E. V. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.03.025 · Cited by 36
Meng, I. D., & Harasawa, I. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.02.022 · Cited by 35
Dourish, C. T., O‘Neill, M. F., Schaffer, L. W., Siegl, P. K. S., & Iversen, S. D. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23166-4 · Cited by 33
The involvement of midbrain astrocyte in the development of morphine tolerance
Harada, S., Nakamoto, K., & Tokuyama, S. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.08.009 · Cited by 32
Chao, Y.-C., Xie, F., Li, X., Guo, R., Yang, N., Zhang, C., Shi, R., Guan, Y., Yue, Y., & Wang, Y. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.03.007 · Cited by 32
Managing Difficult Pain Conditions in the Cancer Patient
Mercadante, S. (2014) · Current Pain and Headache Reports · doi:10.1007/s11916-013-0395-y · Cited by 31
Self-citationThe Patient with Difficult Cancer Pain
Mercadante, S. (2019) · Cancers · doi:10.3390/cancers11040565 · Cited by 28
Self-citationRole of Spinal CXCL1 (GROα) in Opioid Tolerance: A Human-to-rodent Translational Study
Lin, C., Kang, K., Lin, T.-H., Wu, M.-Y., Liou, H., Chuang, W., Sun, W., & Fu, W. (2014) · Anesthesiology · doi:10.1097/aln.0000000000000523 · Cited by 25
Rieb, L. M., Norman, W. V., Martin, R. E., Berkowitz, J., Wood, E., McNeil, R., & Milloy, M. (2016) · Pain · doi:10.1097/j.pain.0000000000000710 · Cited by 25
The Relationship Between Opioids and Immune Signalling in the Spinal Cord
Thomas, J., Mustafa, S., Johnson, J. L., Nicotra, L. L., & Hutchinson, M. R. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-46450-2_11 · Cited by 24
Bobeck, E. N., Ingram, S., Hermes, S. M., Aicher, S. A., & Morgan, M. M. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.10.032 · Cited by 24
Wilson‐Poe, A. R., Lau, B. K., & Vaughan, C. W. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12809 · Cited by 19
Prommer, E. (2006) · Journal of Palliative Medicine · doi:10.1089/jpm.2006.9.488 · Cited by 19
Cited by
Discontinuation of psychotropic medication: a synthesis of evidence across medication classes.
Vinkers, C. H., Kupka, R. W., Penninx, B. W., Ruhé, H. G., van Gaalen, J. M., van Haaren, P. C. F., Schellekens, A. F. A., Jauhar, S., Ramos-Quiroga, J. A., Vieta, E., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02445-4 · Cited by 51
Go, E. J., Hwang, S.-M., Jo, H., Rahman, M. M., Park, J., Lee, J. Y., Jo, Y. Y., Lee, B.-G., Jung, Y., Berta, T., et al. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01342-8 · Cited by 28
Berardino, K., Carroll, A. H., Popovsky, D., Ricotti, R., Civilette, M. D., Sherman, W. F., & Kaye, A. D. (2022) · Orthopedic Reviews · doi:10.52965/001c.35318 · Cited by 14
Efficacy of biofeedback in rehabilitation of musculoskeletal disorders: a systematic review
de la Barra Ortiz, H. A., Matamala, A. M., Inostroza, F. L., Araya, C. L., & Mondaca, V. N. (2022) · Advances in Rehabilitation · doi:10.5114/areh.2022.113241 · Cited by 6
Metadata
- Authors
- Mercadante, S., Arcuri, E., & Santoni, A.
- Venue
- CNS Drugs
- Published
- 2019-10
- Volume
- 33
- Issue
- 10
- Pages
- 943-955
- ISSN
- 1172-7047 (ISSN-L)
- 1179-1934
- OpenAlex
- W2977763422
- Cited by
- 326
- References
- 103
- FWCI
- 29.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.